Noteworthy Wearables News This Week – 13th Jan 2019

January 13, 2019

I was following CES 2019 news feed online and noticed a reduction in wearable tech news compared to 2018. Nevertheless, it’s the quality that counts and there were that few products that caught my eye this year.

Elsewhere, a Switzerland-based company hopes to license their technology to deliver advanced running metrics to any sports watch; think running power!


After buying back Nokia Health, Withings was quick to announce 3 new products at CES 2019. The two that caught my attention was the
soon-to-be FDA-cleared EKG Move and the BPM Core.

The availability of the ECG Move would mean the Apple Watch Series 4 can no longer lay claim to being the only smart watch on the market with FDA cleared ECG readings from the wrist.

What’s impressive about the ECG Move is the 12 months battery life along with all day activity tracking capabilities and connected GPS via mobile device.

Strangely, the ECG Move ships without optical HR sensors; strange because Withings already has a Steel HR sports with Firstbeat technologies. So, the ECG Move would appear to be 2 steps forward and 1 step back.

Perhaps this is the spark of EKG prevalence in wearables, a welcomed move for consumers and for the health industry.

The other notable product from Withings is the BPM Core. This portable blood pressure monitor measures BP, ECG, and detects valvular heart risk.

While wireless blood pressure monitors aren’t new, I like to think Withings has really added value to their wireless BP monitors by adding ECG measurement and a digital stethoscope.

I see value in products that allow individuals to take charge and monitor their own health over time instead of the current model of yearly examinations. Well done Withings.


Omron’s first announced their HeartGuide during CES 2018. After getting FDA clearance, the company is proud to showcase their clinically accurate, wearable blood pressure (BP) monitor watch this time round.

For individuals who have to monitor their BPs, this watch is a godsend. Instead of taking your BP only when you’re near your BP monitors, the HeartGuide watch allows the user to take a clinically accurate BP reading in just 30 seconds, anywhere.

And rather than stopping at just BP, the Omron HeartGuide goes on to keep track of all day activity and sleep as well.

I look forward to the day when the wrist wearable is not simply a fitness device but one that is health-focus heavy with actionable feedback. The challenge then would be for medical practitioners to level up in order to decipher data from patients via wearable tech.


The last company that caught my attention this week is one that isn’t peddling any products. Instead, Myotest is hoping to deliver next generation smart running features for smartphones and smart/sport watches via licensing.

Myotest Integrated Library ® (MIL®) claims that their technology is capable of delivering “in real-time the foundational running biomechanical data such as cadence, step length, ground contact time, vertical oscillation, symmetry, stiffness, regularity and power from almost any type of wearable, including smartwatches at the wrist, with no need for extra accessories or custom equipment. MIL’s achieves an average accuracy of over 95% regardless of where this data is being measured, be it wrist, upper arm or chest. ” 

The more prominent players in the running power sector currently are Stryd, Garmin, and lately, Polar. If Myotest’s technology does take off, we can expect more adoption of this metrics by other wearables and perhaps finally reach a uniform measurement standard for running power.

The idea of a wrist wearable with outstanding fitness focused features (think Myotest running metrics) along with ECG, BP monitoring doesn’t seem too far fetch after all.

Source: Business Wire

No Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.